Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study

Artz, 2013, Older patients/older donors: choosing wisely, Hematology, 70, 10.1182/asheducation-2013.1.70 Deeg, 2010, Who is fit for allogeneic transplantation?, Blood, 116, 4762, 10.1182/blood-2010-07-259358 Rezvani, 2015, Impact of donor age on outcome after allogeneic hematopoietic cell transplantation, Biol Blood Marrow Transplant, 21, 105e112, 10.1016/j.bbmt.2014.09.021 Devine, 2012, A phase II study of allogeneic transplantation for older patients with AML in first complete remission using a reduced intensity conditioning regimen: results from CALGB 100103/BMT CTN 0502 [abstract], Blood, 120, 230, 10.1182/blood.V120.21.230.230 Pulsipher, 2009, Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34 cell dose, Blood, 114, 2606, 10.1182/blood-2009-03-208355 Pulsipher, 2009, Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program, Blood, 113, 3604, 10.1182/blood-2008-08-175323 Richa, 2012, Influence of related donor age on outcomes after peripheral blood stem cell transplantation, Cytotherapy, 14, 707, 10.3109/14653249.2012.681041 Anthias, 2015, The impact of improved JACIE standards on the care of related BM and PBSC donors, Bone Marrow Transplant, 50, 244, 10.1038/bmt.2014.260 Lysak, 2011, Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?, J Clin Apher, 26, 9, 10.1002/jca.20269 Shaw, 2010, Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations, Bone Marrow Transplant, 45, 832, 10.1038/bmt.2010.2 Sacchi, 2008, Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health, Bone Marrow Transplant, 42, 9, 10.1038/bmt.2008.76 Lown, 2014, Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee, Bone Marrow Transplant, 49, 880, 10.1038/bmt.2014.67 Ware, 2002 Derogatis, 1974, The Hopkins Symptom Checklist (HSCL), Behav Sci, 19, 1, 10.1002/bs.3830190102 Derogatis, 1975 Switzer, 1996, Helping unrelated strangers: physical and psychological reactions to the bone marrow donation process among anonymous donors, J Appl Soc Psychol, 26, 469, 10.1111/j.1559-1816.1996.tb02726.x Switzer, 2003, Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors, Transplantation, 75, 1517, 10.1097/01.TP.0000060251.40758.98 Switzer, 2004, Attrition of potential bone marrow donors at two key decision points leading to donation, Transplantation, 77, 1529, 10.1097/01.TP.0000122219.35928.D6 Switzer, 2014, Health-related QoL of bone marrow versus PBSC donors: a pre-specified subgroup analysis from a phase III RCT—BMTCTN protocol 0201, Biol Blood Marrow Transplant, 20, 118, 10.1016/j.bbmt.2013.10.024 Switzer, 1999, Factors associated with attrition from a national bone marrow registry, Bone Marrow Transplant, 24, 313, 10.1038/sj.bmt.1701884 Switzer, 2001, Donating stimulated peripheral blood stem cells vs. bone marrow: do donors experience the procedures differently?, Bone Marrow Transplant, 27, 917, 10.1038/sj.bmt.1703011 AARP Johnson Shen Hanmer, 2006